Matthew Maxwell Donley - 20 Feb 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Signature
/s/ Matthew Maxwell Donley
Issuer symbol
AUPH
Transactions as of
20 Feb 2026
Net transactions value
-$473,774
Form type
4
Filing time
23 Feb 2026, 16:08:05 UTC
Previous filing
05 Jan 2026
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Donley Matthew Maxwell Chief Operating Officer #140, 14315-118 AVENUE, EDMONTON, ALBERTA, CANADA /s/ Matthew Maxwell Donley 23 Feb 2026 0001636642

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Tax liability $473,774 -32,901 -4.7% $14.40 662,900 20 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.